Company profile
Veralox Therapeutics company profile
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Business identity
- Website
- https://www.veralox.com
- Phone number
- (301) 360-3502
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2017-01-01, Year
Headquarters
- Headquarters
- Gas, Kansas, United States
- Postal code
- 21704
- Country code
- US
- Continent
- North America